Health Bayer Secures FDA Approval for Hyrnuo to Treat Lung Cancer Bayer AG has received approval from the United States Food and Drug Administration (FDA) for its new drug Hyrnuo, aimed at treating a prevalent... Editorial1 day ago
Technology Groundbreaking Study Links Microbiota to Antitumor Immunity Research has unveiled a significant connection between gut microbiota and antitumor immunity, specifically in patients undergoing PD-1 blockade monotherapy for advanced cancers. This study,... Editorial15 July, 2025